Johnson & Johnson (JNJ)

These two high-quality dividend payers have had very different fortunes recently.

American States Water has quietly been increasing its dividend for over 70 years.

Vanguard offers three dividend ETFs—VIG, VYM, and VYMI—with distinct yields, holdings, and geographic focus, giving income investors varied ways to access dividend-paying stocks.

Both of these healthcare leaders are Dividend Kings.

Bear markets are a normal part of investing, so you should always own some stocks that are resilient to market downturns.

All three are also solid "forever" holdings, but the next five years could be particularly exciting as each company bounces back from recent challenges.

IHE delivered 53.2% returns over one year with lower volatility and a 0.37% expense ratio, while PBE's quantitative biotech strategy carries higher risk.

Johnson & Johnson's new drugs may offset declining sales due to patent-protection losses.

Johnson & Johnson secures FDA clearance for MONARCH QUEST 3 software, boosting robotic bronchoscopy accuracy with AI. new 3D imaging tools.

While investors treat Wall Street like a casino, stick to these Buffett-style "wonderful investments."

The space company is popular right now, but these other corporations look more attractive.

Whether a recession is coming in 2026 or five years from now, the best investors are always figuring out how to prepare.

The pharmaceutical giant just increased its dividend by 3.1%, now paying $5.36 a share annually.